Saroj Vadhan
M.D. Anderson Cancer Center · UT MD Anderson Cancer Center · UT MDAnderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Saroj Vadhan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02949947 · Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic TherapyM.D. Anderson Cancer Center · terminated · Malignant Neoplasms of Mesothelial and Soft Tissue, Gastrointestinal Stromal Tumor With Neurogenic Differentiation · principal investigator
- Ph2NCT02732015 · Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving ChemotherapyM.D. Anderson Cancer Center · terminated · Locally Advanced Sarcoma · principal investigator
- N/ANCT01490060 · Fosaprepitant in Patients Receiving Ifosfamide-based RegimenM.D. Anderson Cancer Center · completed · Sarcoma, Chemotherapy-induced Nausea and Vomiting, Effects of Chemotherapy · study chair
- Ph2NCT01200485 · Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2M.D. Anderson Cancer Center · completed · Leukemia, Lymphoma · principal investigator
- Ph4NCT00966277 · Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsM.D. Anderson Cancer Center · completed · Pancreatic Cancer, Venous Thromboembolism · study chair
- Ph2NCT00965172 · Caphosol in Sarcoma Patients With MucositisM.D. Anderson Cancer Center · completed · Sarcoma, Oral Mucositis · study chair
- N/ANCT00651755 · Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma PatientsM.D. Anderson Cancer Center · completed · Lymphoma · principal investigator
- Ph2NCT00628628 · Rasburicase in Patients at Risk for Tumor Lysis SyndromeM.D. Anderson Cancer Center · completed · Tumor Lysis Syndrome · principal investigator
- Ph1/Ph2NCT00424645 · Voraxaze for Delayed Methotrexate ClearanceM.D. Anderson Cancer Center · terminated · Hematologic Malignancy, Solid Tumor · principal investigator
- N/ANCT00410488 · Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)M.D. Anderson Cancer Center · completed · Sarcoma, Nausea, Vomiting · principal investigator
- Ph1/Ph2NCT00360438 · Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLSM.D. Anderson Cancer Center · completed · Leukemia, Lymphoma, Tumor Lysis Syndrome · principal investigator
- Ph1/Ph2NCT00299182 · Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's LymphomaM.D. Anderson Cancer Center · completed · Lymphoma · principal investigator
- Ph3NCT00283582 · Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive ChemotherapyM.D. Anderson Cancer Center · completed · Sarcoma · principal investigator
- N/ANCT00283621 · Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and IfosfamideM.D. Anderson Cancer Center · completed · Sarcoma · principal investigator
- Ph2NCT00267046 · Evaluate PKs and Efficacy Assessment of Palifermin in Patients With SarcomaM.D. Anderson Cancer Center · completed · Sarcoma, Oral Mucositis · principal investigator
- Ph3NCT00254436 · A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal PatientsM.D. Anderson Cancer Center · terminated · Gastrointestinal Cancer, Rectal Cancer · principal investigator
- Ph1/Ph2NCT00147225 · AMG 531 in Patients With Advanced Malignancy Receiving Treatment With CarboplatinM.D. Anderson Cancer Center · completed · Solid Tumors, Advanced Cancer · principal investigator
- N/ANCT00113841 · Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple MyelomaM.D. Anderson Cancer Center · completed · Multiple Myeloma · principal investigator
- N/ANCT00038012 · rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving CarboplatinM.D. Anderson Cancer Center · completed · Neoplasms, Gynecologic · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Curcumin/Bioperine in Multiple MyelomaR21CA107217 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2004 to 2005 · $203,850 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:01 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proc Natl Acad Sci U S A · 1985602 citationsRCR 17.0
- Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?Am J Clin Oncol · 200633 citationsRCR 0.9